Martín et al. [25] found that leptin impairs the prognosis in cancers and neurodegenerative disorders by increasing cell susceptibility to inflammatory mediators, supporting its potential as a biomarker and therapeutic target in pathological aging studies. The gene discussed is LEP; the disease is cancer.